Table 1 |
||
|
Clinical characteristics and comparison of the Ofloxacin & Rifampicin and Doxycycline & Rifampicin group |
||
|
Clinical findings |
Doxycycline & Rifampicin group (n = 14) |
Ofloxacin & Rifampicin group (n = 15) |
|
|
||
|
Age (years) (median-range) |
29 (24–61) |
35 (18–60) |
|
Male/Female |
11/3 |
13/2 |
|
Hepatomegaly (n) |
7 |
9 |
|
Fever (n) |
13 |
15 |
|
Arthralgia (n) |
13 |
13 |
|
Headache (n) |
10 |
11 |
|
Sweating (n) |
12 |
10 |
|
Splenomegaly (n) |
7 |
7 |
|
Diagnosis with culture (n) |
4 |
3 |
|
Diagnosis with agglutination (n) |
12 |
13 |
|
Adverse effects |
||
|
- Diarrhea (n) |
1 |
2 |
|
- Nausea and vomiting (n) |
3 |
1 |
|
Complication (n) |
2 Sacroileitis |
1 Sacroileitis ** 1 Orchitis |
|
Relapse (n) |
2 |
2 ** |
|
Duration of fever after starting treatment (mean ± SD) (hours) |
106 ± 26 |
74 ± 30 * |
|
|
||
|
*p < 0.05. ** p > 0.05 |
||
|
Karabay et al. BMC Infectious Diseases 2004 4:18 doi:10.1186/1471-2334-4-18 |
||
